Diabetes Injection Pens Market

Diabetes Injection Pens also called insulin pens are used by people with diabetes to inject insulin. The pens include an insulin cartridge, a dial to measure dosage.

Diabetes Injection Pens Market contains market size and forecasts of Diabetes Injection Pens in global, including the following market information:

• Global Diabetes Injection Pens Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Diabetes Injection Pens Market Sales, 2017-2022, 2023-2028, (K Units)
• Global top five Diabetes Injection Pens companies in 2021 (%)

The global Diabetes Injection Pens market was valued at 4602.5 million in 2021 and is projected to reach US$ 6977.7 million by 2028, at a CAGR of 6.1% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Reusable Insulin Pens Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Diabetes Injection Pens include Novo Nordisk, Eli Lilly, Sanofi, BD, Ypsomed Holding, Dongbao, Owen Mumford, Ganlee and Delfu. etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Diabetes Injection Pens manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Diabetes Injection Pens Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetes Injection Pens Market Segment Percentages, by Type, 2021 (%)

• Reusable Insulin Pens
• Disposable Insulin Pens

Global Diabetes Injection Pens Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetes Injection Pens Market Segment Percentages, by Application, 2021 (%)

• Hospital and Clinic
• Retail Pharmacy
• Online Sales

Global Diabetes Injection Pens Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global Diabetes Injection Pens Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Diabetes Injection Pens revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Diabetes Injection Pens revenues share in global market, 2021 (%)
• Key companies Diabetes Injection Pens sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies Diabetes Injection Pens sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Novo Nordisk
• Eli Lilly
• Sanofi
• BD
• Ypsomed Holding
• Dongbao
• Owen Mumford
• Ganlee
• Delfu